Bayer CropScience Ltd

Bayer CropScience Ltd

₹ 5,202 -0.22%
02 Sep - close price
About

Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]

Key Points

Business Areas

  • Market Cap 23,361 Cr.
  • Current Price 5,202
  • High / Low 6,920 / 4,217
  • Stock P/E 39.4
  • Book Value 634
  • Dividend Yield 2.40 %
  • ROCE 24.8 %
  • ROE 20.0 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 86.9%

Cons

  • Stock is trading at 8.20 times its book value
  • The company has delivered a poor sales growth of 8.68% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
1,667 1,452 1,038 982 1,740 1,617 955 792 1,631 1,738 1,057 1,046 1,915
1,272 1,214 952 777 1,315 1,312 827 695 1,317 1,554 1,037 876 1,566
Operating Profit 395 238 85 206 425 305 128 97 314 184 20 171 348
OPM % 24% 16% 8% 21% 24% 19% 13% 12% 19% 11% 2% 16% 18%
14 14 116 24 21 16 15 29 27 24 32 37 19
Interest 4 8 3 7 8 4 3 5 4 3 4 6 5
Depreciation 23 15 14 27 31 12 15 16 22 14 15 34 27
Profit before tax 382 229 184 195 406 306 124 105 316 190 34 168 335
Tax % 21% 29% 27% 19% 19% 27% 25% 9% 20% 28% -2% 15% 17%
303 163 134 158 328 223 93 96 254 136 34 143 279
EPS in Rs 67.33 36.18 29.93 35.27 73.09 49.60 20.72 21.36 56.56 30.33 7.61 31.89 62.01
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
3,188 3,660 2,769 2,803 2,710 3,167 3,609 4,261 4,734 5,140 5,106 5,473 5,756
2,768 3,144 2,334 2,389 2,300 2,684 2,883 3,450 3,923 4,216 4,147 4,783 5,033
Operating Profit 419 516 435 414 410 483 726 812 812 924 959 691 723
OPM % 13% 14% 16% 15% 15% 15% 20% 19% 17% 18% 19% 13% 13%
91 88 82 70 39 51 -64 69 112 168 76 118 112
Interest 5 5 10 7 11 10 14 13 13 22 20 17 18
Depreciation 65 25 25 29 33 44 65 74 64 80 74 85 91
Profit before tax 441 574 482 448 404 480 583 794 847 990 941 707 727
Tax % 34% 33% 35% 35% 26% 30% 19% 38% 24% 23% 21% 20%
290 383 315 291 300 337 474 493 645 758 740 568 592
EPS in Rs 79.06 104.59 89.13 82.31 87.41 98.18 105.58 109.72 143.58 168.71 164.77 126.38 131.84
Dividend Payout % 7% 20% 19% 21% 21% 18% 24% 105% 104% 77% 85% 99%
Compounded Sales Growth
10 Years: 4%
5 Years: 9%
3 Years: 5%
TTM: 15%
Compounded Profit Growth
10 Years: 4%
5 Years: 0%
3 Years: -2%
TTM: -11%
Stock Price CAGR
10 Years: 3%
5 Years: -3%
3 Years: -1%
1 Year: -18%
Return on Equity
10 Years: 21%
5 Years: 23%
3 Years: 24%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 37 37 35 35 34 34 45 45 45 45 45 45
Reserves 1,706 1,996 1,804 2,021 1,744 2,205 2,528 2,505 2,479 2,667 2,804 2,806
0 0 0 0 0 0 2 26 86 74 47 105
645 740 597 769 756 1,310 1,262 1,663 1,742 1,893 1,701 2,290
Total Liabilities 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,679 4,597 5,246
228 322 290 342 334 440 468 425 468 462 414 470
CWIP 217 1 17 24 36 47 56 76 98 109 119 119
Investments 4 29 68 50 0 0 41 52 38 41 54 35
1,939 2,422 2,062 2,410 2,164 3,062 3,270 3,686 3,749 4,066 4,010 4,622
Total Assets 2,387 2,773 2,437 2,825 2,535 3,549 3,836 4,239 4,353 4,679 4,597 5,246

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
282 200 206 157 121 433 666 687 216 609 952 262
-290 485 16 -8 38 -113 -29 7 64 83 0 86
-480 -42 -590 -73 -581 -158 -148 -556 -703 -613 -656 -619
Net Cash Flow -488 644 -367 76 -421 162 489 138 -424 79 296 -272

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 47 57 53 72 89 81 73 65 77 69 69 63
Inventory Days 98 85 169 178 175 294 206 226 235 268 222 319
Days Payable 51 40 52 67 67 164 101 142 127 129 87 148
Cash Conversion Cycle 94 102 171 184 197 211 177 149 185 208 204 234
Working Capital Days 88 53 92 104 134 116 77 61 84 86 78 88
ROCE % 24% 31% 25% 23% 22% 25% 30% 31% 31% 34% 34% 25%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44% 71.44%
3.10% 3.19% 3.18% 3.18% 3.30% 3.53% 3.62% 3.63% 3.30% 3.42% 3.49% 3.64%
12.76% 12.78% 12.74% 13.06% 13.23% 12.70% 12.80% 12.47% 12.08% 11.69% 11.56% 11.38%
12.71% 12.59% 12.64% 12.32% 12.05% 12.33% 12.15% 12.47% 13.18% 13.45% 13.53% 13.55%
No. of Shareholders 57,89657,04857,25348,40445,32946,90745,85246,20151,28954,28954,21655,753

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls